What are the implications and management of elevated late salivary cortisol levels, specifically 290 and 275, potentially indicating Cushing's syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Elevated Late Salivary Cortisol Levels: Implications and Management

Late salivary cortisol levels of 290 and 275 strongly suggest Cushing's syndrome and require further diagnostic evaluation and appropriate management. 1, 2

Diagnostic Significance

  • Late-night salivary cortisol is a key screening test for Cushing's syndrome, with normal values typically below 3.6 nmol/L (approximately 0.13 μg/dL) 3
  • Values of 290 and 275 (presumed units: nmol/L) are significantly elevated and highly suggestive of Cushing's syndrome with loss of normal circadian rhythm of cortisol secretion 1, 4
  • Late-night salivary cortisol has excellent diagnostic accuracy for Cushing's syndrome with sensitivity of 92-100% and specificity of 93-100% 4
  • These elevated values represent a failure of the normal nocturnal nadir in cortisol production, which is a hallmark of Cushing's syndrome 1

Recommended Diagnostic Algorithm

  1. Confirm Cushing's syndrome diagnosis with additional tests 1:

    • 24-hour urinary free cortisol (UFC) measurement for 3 consecutive days
    • Low-dose dexamethasone suppression test (LDDST)
    • Consider measuring dexamethasone levels during LDDST to improve test interpretability 2
  2. Determine ACTH dependency 2:

    • Measure morning plasma ACTH levels
    • ACTH >5 ng/L suggests ACTH-dependent Cushing's syndrome
    • ACTH <5 ng/L suggests ACTH-independent Cushing's syndrome
  3. Localize the source based on ACTH status 1, 2:

    • For ACTH-dependent disease:
      • Pituitary MRI
      • CRH stimulation test
      • Bilateral inferior petrosal sinus sampling (BIPSS) if MRI is inconclusive
    • For ACTH-independent disease:
      • Adrenal CT or MRI scan

Management Approach

  • Treatment depends on the cause 1, 5:

    • Cushing's disease (pituitary source): transsphenoidal surgery
    • Adrenal adenoma: laparoscopic adrenalectomy
    • Adrenal carcinoma: open adrenalectomy with possible adjuvant therapy
    • Ectopic ACTH: surgical removal of the source when possible
  • Medical therapy options when surgery is contraindicated or unsuccessful 1:

    • Adrenal steroidogenesis inhibitors (ketoconazole, mitotane)
    • Pituitary-directed medications for Cushing's disease
    • Bilateral adrenalectomy for refractory cases

Clinical Implications and Complications

  • Untreated Cushing's syndrome leads to significant morbidity and mortality 5, 6:

    • Cardiovascular: hypertension, increased risk of heart disease and stroke
    • Metabolic: diabetes, obesity, dyslipidemia
    • Musculoskeletal: osteoporosis, fractures, proximal muscle weakness
    • Immunologic: increased susceptibility to infections
    • Psychiatric: depression, anxiety, cognitive impairment
  • Specific symptoms to monitor 1, 6:

    • Central obesity, "moon face," buffalo hump
    • Proximal muscle weakness
    • Wide purple striae, easy bruising
    • Hypertension, hyperglycemia
    • Growth failure in children and adolescents

Important Considerations

  • False positive results can occur with 1, 2:

    • Severe obesity
    • Alcoholism
    • Depression
    • Disrupted sleep-wake cycles
    • Sample contamination (particularly by topical corticosteroids)
  • In children and adolescents, Cushing's syndrome typically presents with weight gain combined with growth failure (decreased height velocity), which distinguishes it from simple obesity 1

  • For patients with suspected cyclic Cushing's syndrome, periodic repeated testing may be necessary as cortisol levels can fluctuate between normal and elevated 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cushing's Syndrome Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Late-night salivary cortisol as a screening test for Cushing's syndrome.

The Journal of clinical endocrinology and metabolism, 1998

Research

Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome.

Nature clinical practice. Endocrinology & metabolism, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.